1. Home
  2. RMBI vs TLSI Comparison

RMBI vs TLSI Comparison

Compare RMBI & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richmond Mutual Bancorporation Inc.

RMBI

Richmond Mutual Bancorporation Inc.

N/A

Current Price

$15.94

Market Cap

248.0M

Sector

Finance

ML Signal

N/A

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

N/A

Current Price

$5.14

Market Cap

270.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RMBI
TLSI
Founded
1887
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.0M
270.2M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
RMBI
TLSI
Price
$15.94
$5.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
40.7K
165.2K
Earning Date
04-23-2026
05-12-2026
Dividend Yield
3.85%
N/A
EPS Growth
27.17
N/A
EPS
0.51
N/A
Revenue
N/A
$45,151,000.00
Revenue This Year
N/A
$35.45
Revenue Next Year
N/A
$37.58
P/E Ratio
$31.18
N/A
Revenue Growth
N/A
53.41
52 Week Low
$12.77
$2.20
52 Week High
$16.59
$7.95

Technical Indicators

Market Signals
Indicator
RMBI
TLSI
Relative Strength Index (RSI) 54.05 56.23
Support Level $15.75 $4.21
Resistance Level $16.17 $5.58
Average True Range (ATR) 0.25 0.27
MACD -0.04 -0.05
Stochastic Oscillator 45.69 57.47

Price Performance

Historical Comparison
RMBI
TLSI

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a bank holding company. Along with its subsidiary, it is mainly engaged in attracting deposits from the general public, as well as brokered deposits, and investing those funds in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one- to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. It also obtains funds by utilizing Federal Home Loan Bank (FHLB) advances. These funds are generally invested in investment securities, including mortgage-backed and mortgage-related securities and agency and municipal bonds. The Group's primary market area includes Wayne and Shelby counties in Indiana and Shelby, Miami, and Franklin counties in Ohio.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: